Does the Treatment Center Matter for AML Survival?

Yes, the treatment center you choose matters significantly for your Acute Myeloid Leukemia (AML) survival. Studies consistently show that patients treated at high-volume, academic, or National Cancer Institute (NCI)-designated cancer centers have significantly better overall survival and lower rates of early mortality compared to those treated at local community hospitals ^[1][2][3]. Because AML is an aggressive and complex blood cancer, managing it safely requires specialized expertise, rapid advanced testing, and medical resources that most local hospitals are simply not equipped to provide.

Why High-Volume Centers Improve Survival

The benefits of traveling to a major cancer center for AML treatment go far beyond simply seeing a specialist. High-volume centers provide structural and technological advantages that directly impact your outcome:

• Lower Risk of Early Complications: Intensive chemotherapy for AML can cause severe, life-threatening side effects. High-volume centers have experienced medical teams that recognize and manage these complications early ^[4]. Research shows that receiving treatment at an NCI-designated center is associated with a 53% reduction in the risk of early mortality ^[5]. In contrast, receiving intensive induction chemotherapy at a lower-volume hospital is an independent predictor of increased inpatient mortality ^[6].
• Rapid Advanced Diagnostics: AML is not just one disease; it is categorized by specific genetic mutations in your cancer cells. High-volume centers can rapidly perform Next-Generation Sequencing (NGS) (a highly sensitive laboratory test that maps out the exact genetic mutations driving your leukemia) ^[7][8]. Knowing your exact genetic makeup quickly allows doctors to prescribe targeted therapies, which is now the standard of care for AML ^[9][7].
• In-House Stem Cell Transplant Teams: For many patients, an allogeneic stem cell transplant (a procedure that replaces your diseased bone marrow with healthy stem cells from a donor) offers the best chance of a cure ^[10][11]. Specialized centers have the complex infrastructure and experienced teams necessary to coordinate this procedure seamlessly, which is critical for improving long-term survival and reducing transplant-related mortality ^[12][13].
• Access to Clinical Trials: Academic centers offer access to cutting-edge, novel therapies through clinical trials ^[14][15]. Because AML treatments are advancing rapidly, having access to these trials means you could receive a highly effective, mechanism-based therapy long before it becomes available at community hospitals ^[16].

Is It Safe to Delay Treatment to Travel?

A common and completely understandable fear is that AML grows so quickly that you must start treatment immediately at the closest hospital. However, recent medical evidence indicates that taking a short delay (e.g., up to 7 to 14 days) to travel to a specialized center and wait for comprehensive diagnostic results is clinically safe ^[17]. The profound survival benefit of receiving a personalized, targeted treatment plan at an expert facility outweighs the risk of a minor delay in starting therapy ^[17][18].

Important Note: Before you travel or transfer, ask your current doctor if you are medically stable enough to make the trip. Newly diagnosed AML patients often have immediate, severe issues like infections, fevers, or very low blood counts that must be stabilized first with antibiotics or blood transfusions.

How to Navigate a Hospital Transfer

If you are currently admitted to a local hospital, you and your family have the right to request a transfer to a specialized center. You can find major academic centers by searching the National Cancer Institute (NCI) online directory of designated cancer centers. Here are practical steps to manage this process:

• Speak With Your Care Team: You can initiate a transfer by asking your current doctor. A helpful way to phrase this is: “I would like to be evaluated and treated at an NCI-designated cancer center. Am I currently stable enough to be transferred, or do we need to stabilize my counts and fever first? How can we start the transfer process today?”
• Consult a Social Worker: Navigating insurance for out-of-network or distant hospitals can be complex. Ask to speak with the hospital’s oncology social worker, case manager, or financial navigator immediately. They can help arrange transportation and confirm insurance coverage.
• Gather Your Medical Records: If you travel, do not go empty-handed. Ask your medical team to prepare physical copies of your lab results and, most importantly, the actual slides from your bone marrow biopsy (a procedure where a needle removes a small sample of bone marrow for testing) so the new center does not have to repeat the procedure unnecessarily.

Alternatives if You Cannot Travel

If traveling to a major cancer center permanently places an impossible burden on you, you still have options to access expert care:

• Shared Care Models: In this approach, you receive your highly intensive treatments—such as induction chemotherapy or a stem cell transplant—at the major academic center, and then transition back to your local community hospital for follow-up blood work, supportive care, and monitoring ^[19].
• Remote Consultations: If you absolutely cannot travel due to failing health, insurance restrictions, or distance, ask your local hematologist to consult remotely with an AML specialist at an academic center to help guide your treatment plan.